P
PFE icon

&Partners’s Pfizer PFE Stock Holding History

&Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
754,925
+24,454
+3% +$640K 0.07% 243
2026
Q1 		$20.5M Buy
730,471
+56,919
+8% +$1.52M 0.1% 189
2025
Q4 		$16.8M Sell
673,552
-27,216
-4% -$686K 0.09% 206
2025
Q3 		$17.8M Sell
700,768
-2,643
-0.4% -$65.2K 0.11% 167
2025
Q2 		$17M Buy
703,411
+50,778
+8% +$1.18M 0.13% 158
2025
Q1 		$16.5M Buy
652,633
+89,713
+16% +$2.35M 0.18% 123
2024
Q4 		$15M Buy
562,920
+200,767
+55% +$5.45M 0.18% 118
2024
Q3 		$10.5M Buy
362,153
+186,758
+106% +$5.45M 0.2% 115
2024
Q2 		$4.91M Buy
175,395
+98,606
+128% +$2.71M 0.21% 106
2024
Q1 		$2.13M Buy
76,789
+22,443
+41% +$623K 0.29% 68
2023
Q4 		$1.59M Buy
54,346
+28,846
+113% +$872K 0.39% 60
2023
Q3 		$846K Buy
25,500
+970
+4% +$34.3K 0.39% 49
2023
Q2 		$900K Buy
24,530
+507
+2% +$19.7K 0.4% 48
2023
Q1 		$980K Sell
24,023
-12
-0% -$518 0.47% 42
2022
Q4 		$1.23M Sell
24,035
-250
-1% -$12K 0.61% 35
2022
Q3 		$1.06M Buy
24,285
+1,755
+8% +$85.3K 0.61% 34
2022
Q2 		$1.18M Buy
22,530
+908
+4% +$46.3K 0.68% 32
2022
Q1 		$1.12M Buy
21,622
+15,270
+240% +$792K 0.63% 29
2021
Q4 		$375K Buy
6,352
+8
+0.1% +$396 0.23% 101
2021
Q3 		$273K Buy
6,344
+10
+0.2% +$443 0.17% 134
2021
Q2 		$248K Buy
+6,334
New +$246K 0.16% 141

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

&Partners's PFE Position: Q2 2026 in Review

&Partners increased its Pfizer (PFE) stake by 3.3% in Q2 2026, buying an estimated $640K and bringing the position to 754,925 shares worth $18.2M. The position accounts for 0.07% of the portfolio, ranked #243.

&Partners first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $20.5M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • &Partners held 754,925 shares of Pfizer worth $18.2M as of Q2 2026.
  • &Partners bought 24,454 Pfizer shares in Q2 2026, an estimated $640K.
  • Pfizer made up 0.07% of &Partners's portfolio in Q2 2026, its #243 holding.
  • &Partners first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
  • &Partners's Pfizer position peaked at $20.5M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.